NCT06033352View on ClinicalTrials.gov

Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Rosacea
Interventions
DEVICE

KTP laser

Treatment with KTP 532 nm laser. Laser fluence depends on erythema intensity and ranges from 7.0 J/cm2 to 11 J/cm2 with a 4-11 mm spot size and 8-12 ms pulse duration.

DRUG

Ivermectin 1% cream

Application of ivermectin 1% cream 1x/day. Interruption for 4 days in case of irritation/redness.

Trial Locations (1)

3010

Department of dermatology, University Hospital Inselspital, Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT06033352 - Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea | Biotech Hunter | Biotech Hunter